Morgan Stanley set a GBX 1,700 ($22.15) target price on GlaxoSmithKline plc (LON:GSK) in a research note released on Thursday morning. The firm currently has a neutral rating on the stock.

A number of other brokerages have also recently commented on GSK. Beaufort Securities upped their price target on shares of GlaxoSmithKline plc from GBX 1,750 ($22.80) to GBX 2,000 ($26.06) and gave the company a buy rating in a research note on Thursday, June 1st. Shore Capital reiterated a hold rating on shares of GlaxoSmithKline plc in a research note on Friday, June 2nd. Liberum Capital reiterated a buy rating and issued a GBX 1,900 ($24.75) target price on shares of GlaxoSmithKline plc in a research note on Tuesday, June 6th. S&P Global set a GBX 1,500 ($19.54) target price on shares of GlaxoSmithKline plc and gave the stock a sell rating in a research note on Tuesday, June 6th. Finally, Jefferies Group LLC increased their price target on shares of GlaxoSmithKline plc from GBX 1,800 ($23.45) to GBX 1,900 ($24.75) and gave the stock a buy rating in a report on Friday, June 16th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and eight have assigned a buy rating to the stock. The stock has an average rating of Hold and a consensus price target of GBX 1,734.73 ($22.60).

GlaxoSmithKline plc (LON:GSK) opened at 1527.50 on Thursday. The company’s 50-day moving average price is GBX 1,638.77 and its 200 day moving average price is GBX 1,627.17. The company’s market capitalization is GBX 74.66 billion. GlaxoSmithKline plc has a 52 week low of GBX 1,446.50 and a 52 week high of GBX 1,745.56.

COPYRIGHT VIOLATION NOTICE: This piece was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another domain, it was stolen and reposted in violation of international trademark & copyright laws. The correct version of this piece can be viewed at https://www.watchlistnews.com/glaxosmithkline-plc-longsk-pt-set-at-gbx-1700-by-morgan-stanley/1463570.html.

The company also recently disclosed a dividend, which will be paid on Thursday, October 12th. Stockholders of record on Thursday, August 10th will be paid a dividend of GBX 19 ($0.25) per share. The ex-dividend date of this dividend is Thursday, August 10th. This represents a dividend yield of 1.23%.

In related news, insider Manvinder Singh Banga purchased 2,267 shares of the company’s stock in a transaction that occurred on Wednesday, July 26th. The shares were purchased at an average price of GBX 1,599 ($20.83) per share, with a total value of £36,249.33 ($47,224.24). Also, insider Victoria Whyte sold 4,820 shares of GlaxoSmithKline plc stock in a transaction on Tuesday, June 20th. The shares were sold at an average price of GBX 1,693 ($22.06), for a total transaction of £81,602.60 ($106,308.75). Insiders purchased a total of 3,150 shares of company stock worth $5,054,075 in the last three months.

GlaxoSmithKline plc Company Profile

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.

Analyst Recommendations for GlaxoSmithKline plc (LON:GSK)

Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with Analyst Ratings Network's FREE daily email newsletter.